Ralph Stephani - Publications

Affiliations: 
St. John's University (New York), School of Pharmacy 
Area:
Pharmaceutical Chemistry, Organic Chemistry, Pharmacology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Liu X, Khadtare N, Patel H, Stephani R, Cantor J. Time-dependent effects of HJP272, an endothelin receptor antagonist, in bleomycin-induced pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. PMID 28619646 DOI: 10.1016/J.Pupt.2017.06.003  0.305
2017 Khadtare N, Stephani R, Korlipara V. Design, synthesis and evaluation of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acid derivatives as ETA receptor selective antagonists using FRET assay. Bioorganic & Medicinal Chemistry Letters. PMID 28462837 DOI: 10.1016/J.Bmcl.2017.04.049  0.349
2015 Patel HJ, Patel PD, Ochiana SO, Yan P, Sun W, Patel MR, Shah SK, Tramentozzi E, Brooks J, Bolaender A, Shrestha L, Stephani R, Finotti P, Leifer C, Li Z, et al. Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94. Journal of Medicinal Chemistry. 58: 3922-43. PMID 25901531 DOI: 10.1021/Acs.Jmedchem.5B00197  0.521
2014 Patel S, Liu X, Liu M, Stephani R, Patel H, Cantor J. HJP272, a novel endothelin receptor antagonist, attenuates lipopolysaccharide-induced acute lung injury in hamsters. Lung. 192: 803-10. PMID 25087133 DOI: 10.1007/S00408-014-9628-Z  0.487
2013 Patel PD, Yan P, Seidler PM, Patel HJ, Sun W, Yang C, Que NS, Taldone T, Finotti P, Stephani RA, Gewirth DT, Chiosis G. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nature Chemical Biology. 9: 677-84. PMID 23995768 DOI: 10.1038/Nchembio.1335  0.416
2012 Sadarangani IR, Bhatia S, Amarante D, Lengyel I, Stephani RA. Synthesis, resolution and anticonvulsant activity of chiral N-1'-ethyl,N-3'-(1-phenylethyl)-(R,S)-2'H,3H,5'H-spiro-(2-benzofuran-1,4'-imidazolidine)-2',3,5'-trione diastereomers. Bioorganic & Medicinal Chemistry Letters. 22: 2507-9. PMID 22401865 DOI: 10.1016/J.Bmcl.2012.02.005  0.589
2010 Patel HJ, Olgun N, Lengyel I, Reznik S, Stephani RA. Synthesis and pharmacological activity of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acids as selective ET(A) antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 6840-4. PMID 20932745 DOI: 10.1016/J.Bmcl.2010.08.074  0.505
2010 Olgun NS, Patel HJ, Stephani R, Lengyel I, Reznik SE. Blockade of endothelin-1 with a novel series of 1,3,6-trisubstituted-2-carboxy-quinol-4-ones controls infection-associated preterm birth. The American Journal of Pathology. 177: 1929-35. PMID 20802183 DOI: 10.2353/Ajpath.2010.100281  0.513
2010 DEVITO SC, STEPHANI RA. ChemInform Abstract: Synthesis and Pharmacological Evaluation of Some Novel 13-(N,N- Dialkylamino-alkyl)benzo(g)(2)benzopyrano(4,3-b)indol-5(13H)ones. Cheminform. 22: no-no. DOI: 10.1002/chin.199145168  0.308
2008 Bhavsar T, Liu XJ, Patel H, Stephani R, Cantor JO. Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke. International Journal of Chronic Obstructive Pulmonary Disease. 3: 477-81. PMID 18990977 DOI: 10.2147/Copd.S2837  0.47
2008 Olgun N, Patel HJ, Stephani R, Wang W, Yen H, Reznik SE. Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery. Canadian Journal of Physiology and Pharmacology. 86: 571-5. PMID 18758506 DOI: 10.1139/Y08-057  0.463
2007 Lengyei I, Patel HJ, Stephani RA. The preparation and characterization of nineteen new phthalidyl spirohydantoins Heterocycles. 73: 349-375. DOI: 10.3987/Com-07-S(U)9  0.543
2006 Patel HJ, Sarra J, Caruso F, Rossi M, Doshi U, Stephani RA. Synthesis and anticonvulsant activity of new N-1',N-3'-disubstituted-2'H,3H,5'H-spiro-(2-benzofuran-1,4'-imidazolidine)-2',3,5'-triones. Bioorganic & Medicinal Chemistry Letters. 16: 4644-7. PMID 16793262 DOI: 10.1016/J.Bmcl.2006.05.102  0.559
2002 Stephani R, Cesare V, Sadarangani I, Lengyel I. Synthesis of new optically active and racemic phenylsuccinamic acids Synthesis. 47-52. DOI: 10.1055/S-2002-19294  0.574
Show low-probability matches.